Ex vivo and in vivo IGF-I antisense RNA strategies for treatment of cancer in humans

Adv Exp Med Biol. 1998;451:27-34. doi: 10.1007/978-1-4615-5357-1_5.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Cell Division
  • Cell Survival / drug effects
  • Genetic Therapy / methods*
  • Genetic Vectors
  • Glial Fibrillary Acidic Protein / analysis
  • Humans
  • Hygromycin B / toxicity
  • Insulin-Like Growth Factor I / analysis
  • Insulin-Like Growth Factor I / biosynthesis
  • Insulin-Like Growth Factor I / genetics*
  • Metallothionein / genetics
  • Mice
  • Neoplasms / therapy
  • Plasmids
  • RNA, Antisense / genetics
  • RNA, Antisense / therapeutic use*
  • Transfection
  • Tumor Cells, Cultured

Substances

  • Glial Fibrillary Acidic Protein
  • RNA, Antisense
  • Hygromycin B
  • Insulin-Like Growth Factor I
  • Metallothionein